3 completed, 1 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow balixafortide: new trials by email Literature Review of balixafortide trials Research Report on balixafortide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer POL6326, Eribulin, Nab paclitaxel - Advanced Breast Cancer | Phase 1 / Phase 2 | Withdrawn | MedSIR | 2022-03-16 | 2023-03-20 | |
| CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) POL6326, Placebo - Large Reperfused ST-Elevation Myocardial Infarction | Phase 2 | Completed | Polyphor Ltd. | 120 | 2013-07-01 | 2016-06-10 |
| Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies POL6326, Leukapheresis, PBSC Transplant - Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 / Phase 2 | Completed | Polyphor Ltd. | 38 | 2012-04-01 | 2016-02-26 |
| Exploratory Study on POL6326 in Stem Cell Mobilization POL6326 - Multiple Myeloma | Phase 2 | Completed | Polyphor Ltd. | 21 | 2009-04-01 | 2014-04-23 |
Multiple Myeloma (2) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · ST Elevation Myocardial Infarction (1)
Polyphor Ltd. (3) · MedSIR (1)
Germany (2) · Austria (1) · Hungary (1) · Poland (1) · United Kingdom (1) · United States (1)
Daniel Couriel, M.D. (1) · Hartmut Goldschmidt, MD (1) · Kai C. Wollert, MD (1) · Peter Kaufman, MD (1)